Biotech Adds United Arab Emirates to Sucanon Distribution

28-Nov-2007

Biotech Holdings reports that it has signed an agreement with a private company (the "UAE Distributor"), pursuant to which, for a period of three years with an option to renew, the UAE Distributor will have an exclusive right to market and distribute Sucanon Type II diabetes drug in the United Arab Emirates including Dubai.

Pursuant to the agreement, the UAE distributor will have the option of receiving Sucanon either in pre-mix form from Canada or in tableted form from the Company's contract tableter in Mexico.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances